VRG-101

N/A

Report date: 2023/01/14 16:14:14

Base Information

Drug NameVRG-101
Drug Alias NameVRG-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1-phosphatidylinositol 3-phosphate 5-kinase inhibitors
Targets1-phosphatidylinositol 3-phosphate 5-kinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerge Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVerge Genomics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A